Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo

NCT00149292 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: LY2140023
DRUG: olanzapine
DRUG: placebo

Sponsor

Denovo Biopharma LLC